Mohan, N.; Agrawal, A.; Shen, Y.; Winarski, K.L.; Endo, Y.; Dokmanovic, M.; Schmiel, D.; Zheng, J.; Rotstein, D.S.; Pelosof, L.C.;
et al. Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1. Pharmaceutics 2022, 14, 1381.
https://doi.org/10.3390/pharmaceutics14071381
AMA Style
Mohan N, Agrawal A, Shen Y, Winarski KL, Endo Y, Dokmanovic M, Schmiel D, Zheng J, Rotstein DS, Pelosof LC,
et al. Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1. Pharmaceutics. 2022; 14(7):1381.
https://doi.org/10.3390/pharmaceutics14071381
Chicago/Turabian Style
Mohan, Nishant, Atul Agrawal, Yi Shen, Katie L. Winarski, Yukinori Endo, Milos Dokmanovic, Deborah Schmiel, Jiwen Zheng, David S. Rotstein, Lorraine C. Pelosof,
and et al. 2022. "Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1" Pharmaceutics 14, no. 7: 1381.
https://doi.org/10.3390/pharmaceutics14071381
APA Style
Mohan, N., Agrawal, A., Shen, Y., Winarski, K. L., Endo, Y., Dokmanovic, M., Schmiel, D., Zheng, J., Rotstein, D. S., Pelosof, L. C., & Wu, W. J.
(2022). Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1. Pharmaceutics, 14(7), 1381.
https://doi.org/10.3390/pharmaceutics14071381